Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
YM BioSciences
Endpoints of the trial are as follows:
primary: overall survival; secondary: response rate, progression free survival, toxicity, neurocognitive function.
Age
16–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Histological proof of breast cancer
Documented evidence of metastatic and/or recurrent breast cancer
Presence of at least one bi-dimensional or uni-dimensional lesion